Engineered polypeptides and uses thereof
US11858980B2 · kind B2 · utility
0Cited by
52References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 2, 2017 |
| Grant date | Jan 2, 2024 |
| Priority date | — |
| Expiry date | Aug 2, 2037 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Polypeptides, such as antibody molecules and fusion proteins, comprising an Fc region, are disclosed. The polypeptides can be used to treat, prevent, and/or diagnose disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.